Literature DB >> 22147121

Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis.

Monika Edelbauer1, Sudhir Kshirsagar, Magdalena Riedl, Heiko Billing, Burkhard Tönshoff, Dieter Haffner, Jörg Dötsch, Gottfried Wechselberger, Lutz T Weber, Elisabeth Steichen-Gersdorf.   

Abstract

BACKGROUND: Endothelial cell injury plays a key role in the pathogenesis of lupus nephritis (LN) and atherosclerosis. The aim of this study was to identify factors involved in the process of endothelial damage in children and adolescents with LN.
METHODS: We evaluated the relationship between plasma vascular endothelial growth factor (VEGF), its soluble receptors sVEGFR-1 and sVEGFR-2 and markers of endothelial inflammation and injury (angiopoietin-2 and thrombomodulin, respectively) in 23 children and adolescents with LN (active LN, n = 14; inactive LN, n = 9; mean age 15 years) and 20 healthy controls (HC; mean age 12 years).
RESULTS: VEGF, sVEGFR-1, angiopoietin-2 and thrombomodulin levels were significantly higher in children and adolescents with active LN than in patients in remission or HC. In active LN, however, VEGF was inversely related to sVEGFR-1 (r = -0.802, p < 0.001), angiopoietin-2 (r = -0.684, p = 0.007) and thrombomodulin (r = -0.697, p = 0.006). There was a significant positive correlation between sVEGFR-1 and thrombomodulin (r = 0.814, p < 0.0001), but sVEGFR-2 did not significantly differ between the patient groups and did not correlate with thrombomodulin (r = 0.046, p = 0.833).
CONCLUSIONS: sVEGFR-1 may play an important role in promoting endothelial damage in children and adolescents with active LN and could possibly be used to monitor disease severity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22147121     DOI: 10.1007/s00467-011-2062-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  51 in total

1.  The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism.

Authors:  Marion Scharpfenecker; Ulrike Fiedler; Yvonne Reiss; Hellmut G Augustin
Journal:  J Cell Sci       Date:  2005-02-01       Impact factor: 5.285

2.  Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.

Authors:  Lena Schiffer; Ramalingam Bethunaickan; Meera Ramanujam; Weiqing Huang; Mario Schiffer; Haiou Tao; Michael P Madaio; Michael M Madaio; Erwin P Bottinger; Anne Davidson
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

3.  Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients.

Authors:  Qunying Guo; Juan Jesús Carrero; Xueqing Yu; Peter Bárány; Abdul Rashid Qureshi; Monica Eriksson; Björn Anderstam; Michal Chmielewski; Olof Heimbürger; Peter Stenvinkel; Bengt Lindholm; Jonas Axelsson
Journal:  Nephrol Dial Transplant       Date:  2009-06-26       Impact factor: 5.992

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 5.  The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?

Authors:  C B Narshi; I P Giles; A Rahman
Journal:  Lupus       Date:  2010-12-07       Impact factor: 2.911

6.  Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

Authors:  Helena Pavlakovic; Jürgen Becker; Romulo Albuquerque; Jörg Wilting; Jayakrishna Ambati
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

7.  Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis.

Authors:  Hai Tao Yuan; Peter G Tipping; Xiao Zhong Li; David A Long; Adrian S Woolf
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

8.  VEGF(165) mediates glomerular endothelial repair.

Authors:  T Ostendorf; U Kunter; F Eitner; A Loos; H Regele; D Kerjaschki; D D Henninger; N Janjic; J Floege
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

9.  Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.

Authors:  H P Gerber; A McMurtrey; J Kowalski; M Yan; B A Keyt; V Dixit; N Ferrara
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

10.  Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).

Authors:  G Banfi; T Bertani; V Boeri; T Faraggiana; G Mazzucco; G Monga; G Sacchi
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

View more
  9 in total

1.  Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.

Authors:  Mariane dos Santos; Rafael N Bringhenti; Patrícia G Rodrigues; Jonathan F do Nascimento; Sane V Pereira; Rafael Zancan; Odirlei A Monticielo; Andrese A Gasparin; Waldir P de Castro; Francisco V Veronese
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 2.  Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.

Authors:  Mallorie Boron; Tiffany Hauzer-Martin; Joseph Keil; Xue-Long Sun
Journal:  TH Open       Date:  2022-07-11

Review 3.  Urine biomarkers in juvenile-onset SLE nephritis.

Authors:  Louise Watson; Michael W Beresford
Journal:  Pediatr Nephrol       Date:  2012-05-16       Impact factor: 3.714

4.  Meta-analysis of associations of vascular endothelial growth factor protein levels and -634G/C polymorphism with systemic lupus erythematosus susceptibility.

Authors:  Wenzhuang Tang; Tianbiao Zhou; Zhiqing Zhong; Hongzhen Zhong
Journal:  BMC Med Genet       Date:  2019-03-22       Impact factor: 2.103

5.  Effects of Lactobacillus plantarum HFY15 on Lupus Nephritis in Mice by Regulation of the TGF-β1 Signaling Pathway.

Authors:  Lin Cheng; Pu Yao; Hongping Wang; Qian Yuan; Xiaowen Wang; Wei Feng; Fengjun Sun; Qian Wang
Journal:  Drug Des Devel Ther       Date:  2022-08-26       Impact factor: 4.319

6.  Alterations in Systemic Extracellular Heme and Hemopexin Are Associated With Adverse Clinical Outcomes in Ugandan Children With Severe Malaria.

Authors:  Robyn E Elphinstone; Andrea L Conroy; Michael Hawkes; Laura Hermann; Sophie Namasopo; H Shaw Warren; Chandy C John; W Conrad Liles; Kevin C Kain
Journal:  J Infect Dis       Date:  2016-08-11       Impact factor: 5.226

7.  Efficient therapy of ischaemic lesions with VEGF121-fibrin in an animal model of systemic sclerosis.

Authors:  Shadab Allipour Birgani; Marion Mailänder; Ines Wasle; Hermann Dietrich; Johann Gruber; Oliver Distler; Roswitha Sgonc
Journal:  Ann Rheum Dis       Date:  2015-09-11       Impact factor: 19.103

Review 8.  Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression.

Authors:  Katsuyuki Tanabe; Yasufumi Sato; Jun Wada
Journal:  Int J Mol Sci       Date:  2018-06-24       Impact factor: 5.923

9.  Gene polymorphisms and serum levels of sVEGFR-1 in patients with systemic lupus erythematosus.

Authors:  Zhi-Chao Yuan; Wang-Dong Xu; Jia-Min Wang; Qian Wu; Jie Zhou; An-Fang Huang
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.